Pharmacokinetic profile of rizatriptan 10-mg tablet and 10-mg orally disintegrating tablet administered with or without water in healthy subjects: an open-label, randomized, single-dose, 3-period crossover study.
about
A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future.Bioequivalence Study of Two Orodispersible Rizatriptan Formulations of 10 mg in Healthy Volunteers.Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design.The triptans.Long-Term Open-Label Safety Study of Rizatriptan Acute Treatment in Pediatric MigraineursApplication of a Reliable LC-MS/MS Method for Determination of Rizatriptan in Healthy Subject Samples: Demonstration of Assay Reproducibility by Incurred Sample Reanalysis
P2860
Pharmacokinetic profile of rizatriptan 10-mg tablet and 10-mg orally disintegrating tablet administered with or without water in healthy subjects: an open-label, randomized, single-dose, 3-period crossover study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pharmacokinetic profile of riz ...... ose, 3-period crossover study.
@en
type
label
Pharmacokinetic profile of riz ...... ose, 3-period crossover study.
@en
prefLabel
Pharmacokinetic profile of riz ...... ose, 3-period crossover study.
@en
P2093
P2860
P356
P1476
Pharmacokinetic profile of riz ...... ose, 3-period crossover study.
@en
P2093
Anthony Rodgers
Carolyn M Hustad
Franck Skobieranda
Harry Alcorn
Karen E Ramsey
Susan Woll
Suzanne K Swan
P2860
P304
P356
10.1177/0091270005284194
P577
2006-02-01T00:00:00Z